Rapid diagnostic algorithms as a screening tool for tuberculosis: an assessor blinded cross-sectional study. 2012

Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University Vienna, Vienna, Austria.

BACKGROUND A major obstacle to effectively treat and control tuberculosis is the absence of an accurate, rapid, and low-cost diagnostic tool. A new approach for the screening of patients for tuberculosis is the use of rapid diagnostic classification algorithms. METHODS We tested a previously published diagnostic algorithm based on four biomarkers as a screening tool for tuberculosis in a Central European patient population using an assessor-blinded cross-sectional study design. In addition, we developed an improved diagnostic classification algorithm based on a study population at a tertiary hospital in Vienna, Austria, by supervised computational statistics. RESULTS The diagnostic accuracy of the previously published diagnostic algorithm for our patient population consisting of 206 patients was 54% (CI: 47%-61%). An improved model was constructed using inflammation parameters and clinical information. A diagnostic accuracy of 86% (CI: 80%-90%) was demonstrated by 10-fold cross validation. An alternative model relying solely on clinical parameters exhibited a diagnostic accuracy of 85% (CI: 79%-89%). CONCLUSIONS Here we show that a rapid diagnostic algorithm based on clinical parameters is only slightly improved by inclusion of inflammation markers in our cohort. Our results also emphasize the need for validation of new diagnostic algorithms in different settings and patient populations.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008297 Male Males
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
March 2017, Integrative medicine research,
Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
October 2025, Diabetology & metabolic syndrome,
Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
October 2020, International journal of environmental research and public health,
Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
January 2023, Lancet regional health. Americas,
Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
September 2018, EBioMedicine,
Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
September 2025, Journal of thermal biology,
Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
November 2018, BMC infectious diseases,
Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
June 1990, American journal of obstetrics and gynecology,
Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
January 2021, BMC geriatrics,
Franz Ratzinger, and Harald Bruckschwaiger, and Martin Wischenbart, and Bernhard Parschalk, and Delmiro Fernandez-Reyes, and Heimo Lagler, and Alexandra Indra, and Wolfgang Graninger, and Stefan Winkler, and Sanjeev Krishna, and Michael Ramharter
September 2020, Cureus,
Copied contents to your clipboard!